N-(biphenyl-2-yl)-3-(N-(2,5-dimethylphenyl)sulfamoyl)-4-Methylbenzamide
N-(biphenyl-2-yl)-3-(N-(2,5-dimethylphenyl)sulfamoyl)-4-Methylbenzamide结构式
|
常用名 | N-(biphenyl-2-yl)-3-(N-(2,5-dimethylphenyl)sulfamoyl)-4-Methylbenzamide | 英文名 | N-(biphenyl-2-yl)-3-(N-(2,5-dimethylphenyl)sulfamoyl)-4-Methylbenzamide |
|---|---|---|---|---|
| CAS号 | 824981-55-7 | 分子量 | 470.58300 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C28H26N2O3S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Differential mechanisms of action of the mucolipin synthetic agonist, ML-SA1, on insect TRPML and mammalian TRPML1.
Cell Calcium 56(6) , 446-56, (2014) Mucolipin synthetic agonist 1 (ML-SA1) was recently identified to activate mammalian TRPML channels and shown to alleviate lipid accumulation in lysosomes of cellular models of lysosome storage diseases, mucolipidosis type IV (MLIV) and Niemann-Pick's disease... |
|
|
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.
Mol. Pharmacol. , (2009) The role of neuropeptide Y Y2 receptor (Y2R) in human diseases such as obesity, mood disorders, and alcoholism could be better resolved by the use of small-molecule chemical probes that are substantially different from the currently available Y2R antagonist, ... |
期刊文献综述：
更多...